Market revenue in 2023 | USD 40.6 million |
Market revenue in 2030 | USD 92.9 million |
Growth rate | 12.5% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.64% in 2023. Horizon Databook has segmented the India real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
Real-World Evidence (RWE) is clinical data obtained by Real World Data (RWD) analysis of use and prospective advantages or dangers of a medical product. RWD contains a wide range of information, such as electronic health records, insurance information, and product & disease registries.
India provides a one-of-a-kind opportunity to perform RWE research in various fields, including health economics and outcomes. An RWE study was conducted in India, according to data from the National Library of Medicine, in 2019, there is no demand for RWE research from insurance companies, patient organizations, or authorities in the country.
As a result, pharmaceutical firms undertake most of these research studies. Hence, such initiatives and studies in the country are expected to contribute further to market growth. Furthermore, increasing government initiatives to digitize healthcare infrastructure are expected to drive the market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account